Polycaprolactone-based neurotherapeutic delivery of rasagiline targeting behavioral and biochemical deficits in Parkinson’s disease

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Drug Delivery and Translational Research

• Publication date

  2019-03-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s13346-019-00625-2PMID 30877626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The neuroprotective agent Rasagiline mesylate attenuates cardiac remodeling after experimental myocardial infarction

  2017cited by this paper
• Polymer based microspheres of aceclofenac as sustained release parenterals for prolonged anti-inflammatory effect.

  2017cited by this paper
• Beneficial effects of lycopene against haloperidol induced orofacial dyskinesia in rats: Possible neurotransmitters and neuroinflammation modulation.

  2016cited by this paper
• Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.

  2015cited by this paper
• Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson’s disease

  2014cited by this paper
• Genetics of Parkinson's disease: the yield.

  2014cited by this paper
• [Epidemiology of Parkinson's disease].

  2013cited by this paper
• Controlled release of rasagiline mesylate promotes neuroprotection in a rotenone-induced advanced model of Parkinson's disease.

  2012cited by this paper
• Development and evaluation of stavudine loaded injectable polymeric particulate systems.

  2011cited by this paper
• Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline

  2010cited by this paper
• Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease

  2009cited by this paper
• Design and Evaluation of Niacin Microspheres

  2009cited by this paper
• Oxidative Stress in Parkinson's Disease

  2008cited by this paper
• Microencapsulation by solvent evaporation: state of the art for process engineering approaches.

  2008cited by this paper
• Cyclooxygenase inhibition attenuates 3‐nitropropionic acid‐induced neurotoxicity in rats: possible antioxidant mechanisms

  2007cited by this paper
• Epidemiology of Parkinson's disease.

  2006cited by this paper
• Chapte B7 - Utility of 6-hydroxydopamine lesioned rats in the preclinical screening of novel treatments for Parkinson disease

  2005cited by this paper
• Characteristics of felodipine-located poly(epsilon-caprolactone) microspheres.

  2005cited by this paper
• The Role of Early Life Environmental Risk Factors in Parkinson Disease: What Is the Evidence?

  2005cited by this paper
• Clinical Pharmacology of Rasagiline: A Novel, Second‐Generation Propargylamine for the Treatment of Parkinson Disease

  2005cited by this paper
• Characteristics of felodipine-located poly(ε-caprolactone) microspheres

  2005cited by this paper
• Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse.

  1999cited by this paper
• Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods.

  1998cited by this paper
• Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.

  1998cited by this paper
• Neurological and Behavioral Outcomes of Focal Cerebral Ischemia in Rats

  1992cited by this paper
• Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase.

  1978cited by this paper
• Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite.

  1974cited by this paper
• MECHANISMS OF LIPID PEROXIDE FORMATION IN TISSUES. ROLE OF METALS AND HAEMATIN PROTEINS IN THE CATALYSIS OF THE OXIDATION UNSATURATED FATTY ACIDS.

  1965cited by this paper
• Determination of serum proteins by means of the biuret reaction.

  1949cited by this paper
• Licensed under Creative Commons Attribution Cc by Oxidative Stress in Parkinson's Disease

  year unknowncited by this paper

• Repurposing Rasagiline Mesylate Nanoparticles for Antidepressant Activity: in silico and in vitro Investigations

  2025cites this paper
• From Bench to Brain: Translating EV and Nanocarrier Research into Parkinson’s Disease Therapies

  2025cites this paper
• Terpene-augmented novasomal gels for the sustainment of rasagiline mesylate delivery; A new approach for treating Parkinson's disease induced by rotenone in rats

  2024cites this paper
• Trends on Novel Targets and Nanotechnology-Based Drug Delivery System in the Treatment of Parkinson's disease: Recent Advancement in Drug Development.

  2024cites this paper
• Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson’s Disease

  2023cites this paper
• The Management of Parkinson’s Disease: An Overview of the Current Advancements in Drug Delivery Systems

  2023cites this paper
• Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems

  2022cites this paper
• Development of rasagiline mesylate loaded solid lipid nanoparticles in a thermosensitive mucoadhesive gel: Formulation design using DoE, in-vitro and ex-vivo characterization

  2021cites this paper
• Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease: Past, Present, and Future

  2021cites this paper
• Biomaterials and stem cells as drug/gene delivery vehicles for Parkinson's treatment: an update.

  2021cites this paper
• Application of neurotoxin- and pesticide-induced animal models of Parkinson’s disease in the evaluation of new drug delivery systems

  2021cites this paper
• Long acting polycaprolactone based parenteral formulation of aripiprazole targeting behavioral and biochemical deficit in schizophrenia.

  2020cites this paper